Eva Hoke

Dose Escalation Studies of Cytarabine, Daunorubicin, and Etoposide With and Without Multidrug Resistance Modulation With PSC-833 in Untreated Adults With Acute Myeloid Leukemia Younger Than 60 Years: Final Induction Results of Cancer and Leukemia Group B Study 9621

Jonathan E. Kolitz, Stephen L. George, Richard K. Dodge et al. · Journal of Clinical Oncology · 2004 · 153 citations · Full text

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Jonathan E. Kolitz, Stephen L. George, Guido Marcucci et al. · Blood · 2010 · 128 citations · Full text

Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)

Meir Wetzler, D. Watson, Wendy Stock et al. · Haematologica · 2013 · 98 citations · Full text

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002

David A. Rizzieri, Jeffrey L. Johnson, John C. Byrd et al. · British Journal of Haematology · 2014 · 93 citations · Full text

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)

William Blum, Ben L. Sanford, Rebecca B. Klisovic et al. · Leukemia · 2016 · 82 citations · Full text

Hematological Malignancy, First Remission, Medicine +8